Controlling exit site infections: does it decrease the incidence of catheter-related bacteremia in children on...

Area of Science:

• Nephrology
• Infectious Diseases
• Medical Devices

Background:

• Catheter-related bacteremia (CRB) is a significant complication in hemodialysis patients.
• Exit site infections (ESI) are a potential precursor to CRB.
• Preventive strategies at the catheter exit site are crucial for patient safety.

Purpose of the Study:

• To evaluate the impact of a chlorhexidine-impregnated dressing (Biopatch) on CRB incidence and etiology.
• To assess the effect of Biopatch on exit site infections (ESI) in tunneled-cuffed hemodialysis catheters.
• To determine if Biopatch influences overall catheter survival time.

Main Methods:

• Retrospective study over 5 years at a single center.
• Comparison between pre-Biopatch Era (betadine and transparent dressing) and Biopatch Era (Biopatch applied weekly).
• Analysis of ESI, CRB incidence, microbiological data, and catheter survival.

Main Results:

• Biopatch significantly decreased the incidence of exit site infections (P<0.05).
• No significant difference in the incidence or microbiological distribution of CRB between the two eras.
• Improved ESI rates did not affect overall catheter survival time.

Conclusions:

• While Biopatch reduces ESI, it does not lower CRB rates or improve catheter survival.
• Antimicrobial sensitivities differ between ESI and CRB, suggesting distinct pathogenesis.
• Findings support intraluminal contamination as the primary route for CRB, rather than extraluminal spread from the exit site.